Worcester, MANCT07223229Now EnrollingIRB Ready

Non-segmental Vitiligo Clinical Trial in Worcester, MA

Access cutting-edge non-segmental vitiligo treatment through this clinical trial at a research site in Worcester. Study-provided care at no cost to qualified participants.

Sponsored by Elixiron Immunotherapeutics (Hong Kong) Ltd.

Quick Self-Assessment

See if you qualify for this Worcester location

Preparing your pre-screening questions…

Expert Care in Worcester

Access non-segmental vitiligo specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-segmental vitiligo treatment provided free

Apply for This Worcester Location

Check if you qualify for this non-segmental vitiligo clinical trial in Worcester, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Worcester

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Worcester site if eligible
  4. 4Begin participation

About This Non-segmental Vitiligo Study in Worcester

The primary purpose of this study is to evaluate whether the drug EI-001 can help improve vitiligo symptoms. EI-001 is a novel antibody drug that affects the immune system to decrease uncontrolled inflammation. EI-001 has been investigated in human cell cultures, animal studies, and in a Phase 1 healthy volunteer study. The results so far show that EI-001 is a tolerable and potential new treatment for immune diseases such as vitiligo.

Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.

Who Can Participate

Inclusion Criteria

Able to understand and voluntarily sign the informed consent form (ICF).
Male or female, aged 18-65 years at the time of consent.
BMI 18-38 kg/m² and weight ≥ 40 kg at consent. Clinically diagnosed non-segmental vitiligo (NSV) for at least 3 months, and meets one of the following:
Inadequate response to approved treatments:
Topical therapy (e.g., corticosteroids, calcineurin inhibitors, or JAK inhibitors) ≥ 3 months,
Phototherapy ≥ 6 months, or Oral therapy (e.g., corticosteroids, calcineurin inhibitors) ≥ 3 months.
Or unable to use these treatments due to contraindications, intolerance, or unsuitability.
Depigmentation extent meeting all of the following: Facial BSA (F-BSA) ≥ 0.5%, Facial VASI (F-VASI) ≥ 0.5, Total BSA (T-BSA) between 5% and 60%, Total VASI (T-VASI) ≥ 5.
Agree to discontinue all vitiligo treatments from screening until final follow-up.
If not previously vaccinated against zoster, agree to complete vaccination before Day 1.
Contraception
Not applicable to females of non-childbearing potential (surgically sterile or postmenopausal ≥12 months, confirmed by FSH at screening).

Exclusion Criteria

Non-eligible skin conditions: Other types of vitiligo (e.g., segmental) or other depigmentation disorders (e.g., piebaldism, leprosy, post-inflammatory hypopigmentation, tinea versicolor, etc.), or ≥30% leukotrichia on face or body.
Psychiatric risk
Recent vitiligo treatments
Surgical treatments or depigmenting agents (e.g., monobenzone)
High-dose steroids
Pregnancy or lactation
Abnormal Medical conditions
Prohibited prior therapies
Cardiac abnormalities
Abnormal chest X-ray
Renal impairment
Clinically significant abnormal laboratory results at screening, per investigator judgment.
Viral infections:
Hypersensitivity: Known allergy or severe reaction to EI-001 or its excipients.
Compliance concerns: Any condition that would make it difficult for the subject to follow the study schedule, receive treatment, attend visits, or could interfere with study objectives, data interpretation, or participant safety.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Worcester?

Yes, this clinical trial (NCT07223229) has an active research site in Worcester, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-segmental Vitiligo Treatment Options in Worcester, MA

If you're searching for non-segmental vitiligo treatment options in Worcester, MA, this clinical trial (NCT07223229) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Worcester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-segmental vitiligo specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-segmental vitiligo clinical trials near you to find additional studies recruiting in your area.

More Vitiligo Trials in Worcester, MA

See all vitiligo clinical trials recruiting in Worcester — not just this study.

Browse Vitiligo Trials in Worcester →

Browse More Trials by Condition

Vitiligo TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Worcester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Worcester, MA